title: Huge growth seen in hepatitis C market.
abstract: As better drugs from a variety of pharmaceutical industry players enter a market with millions of untreated patients, U.S. spending on hepatitis C treatments is expected to rise from $2.1 billion in 2012 to $6.5 billion in 2022.
authors.forename: Kunj
authors.initials: K
authors.lastname: Gohil